Immunology and Microbiology
Myositis
98%
Dermatomyositis
45%
Autoantibodies
33%
Polymyositis
31%
Autoimmune Disease
21%
COVID-19
21%
HLA DRB1 Antigen
17%
Inflammatory Arthritis
17%
Vaccination Policy
16%
Haplotype
14%
Monospecific Antibody
14%
Single Nucleotide Polymorphism
13%
Autoimmune Rheumatic Disease
12%
Vaccine Efficacy
11%
Tumor Necrosis Factor
10%
Allele
9%
Immunogenetics
8%
Inclusion Body Myositis
8%
Genotype
6%
Systemic Scleroderma
6%
Autoantigen
6%
Psoriatic Arthritis
6%
Connective Tissue
5%
Drug Concentration
5%
Immunoprecipitation
5%
Systemic Lupus Erythematosus
5%
Genome-Wide Association Study
5%
Medicine and Dentistry
Myositis
100%
Autoimmune Disease
27%
Diseases
25%
COVID-19 Vaccination
24%
Dermatomyositis
23%
Polymyositis
16%
Inclusion Body Myositis
15%
COVID-19
13%
Autoimmune Rheumatic Disease
11%
Adverse Event
10%
Myopathy
10%
Autoantibodies
10%
Disease Activity
9%
Psoriatic Arthritis
8%
Psoriasis
8%
Rheumatic Disease
7%
Diagnosis
7%
Rheumatoid Arthritis
7%
Symptom
7%
Malignant Neoplasm
7%
HLA-DRB1
7%
Systemic Autoimmune Disease
6%
Infection
5%
Inflammatory Disorder
5%
Systemic Scleroderma
5%
Statin
5%
Tumor Necrosis Factor
5%
Oxidoreductase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myositis
54%
Autoimmune Disease
29%
Vaccination Policy
26%
Disease
20%
Adverse Event
14%
Rheumatoid Arthritis
10%
Rheumatic Disease
9%
Infection
8%
Myopathy
7%
Dermatomyositis
6%
Tumor Necrosis Factor Inhibitor
6%
Disease Activity
6%
Psoriatic Arthritis
5%
Statin (Protein)
5%